trial · primary record
Valbenazine
Chorea, Huntington
| Phase | Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 154 |
| Primary completion | 2025-11-05 |
| Primary endpoint | Number of Participants with Treatment-Emergent Adverse Events (TEAEs) |
| Registry ID | NCT04400331 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:10.522Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04400331
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.